Medical Care
Regenerative Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Apr 15, 24
- ID: 170311
- Pages: 164
- Figures: 240
- Views: 23
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.
The global market for Regenerative Medicine was estimated to be worth US$ 33370 million in 2023 and is forecast to a readjusted size of US$ 115660 million by 2030 with a CAGR of 19.2% during the forecast period 2024-2030
Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.
North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.
In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Regenerative Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Regenerative Medicine by region & country, by Type, and by Application.
The Regenerative Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regenerative Medicine.
Market Segmentation
By Company
J & J (DePuy Synthes)
Medtronic
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Cook Biotech
Japan Tissue Engineering
Segment by Type:
Cell Therapy
Tissue Engineering
Biomaterial
Other
Segment by Application
Dermatology
Cardiovascular
CNS
Orthopedic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Regenerative Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Regenerative Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Regenerative Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.
The global market for Regenerative Medicine was estimated to be worth US$ 33370 million in 2023 and is forecast to a readjusted size of US$ 115660 million by 2030 with a CAGR of 19.2% during the forecast period 2024-2030
Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.
North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.
In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Regenerative Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Regenerative Medicine by region & country, by Type, and by Application.
The Regenerative Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regenerative Medicine.
Market Segmentation
By Company
J & J (DePuy Synthes)
Medtronic
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Cook Biotech
Japan Tissue Engineering
Segment by Type:
Cell Therapy
Tissue Engineering
Biomaterial
Other
Segment by Application
Dermatology
Cardiovascular
CNS
Orthopedic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Regenerative Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Regenerative Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Regenerative Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Regenerative Medicine Product Introduction
1.2 Global Regenerative Medicine Market Size Forecast
1.3 Regenerative Medicine Market Trends & Drivers
1.3.1 Regenerative Medicine Industry Trends
1.3.2 Regenerative Medicine Market Drivers & Opportunity
1.3.3 Regenerative Medicine Market Challenges
1.3.4 Regenerative Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Regenerative Medicine Players Revenue Ranking (2023)
2.2 Global Regenerative Medicine Revenue by Company (2019-2024)
2.3 Key Companies Regenerative Medicine Manufacturing Base Distribution and Headquarters
2.4 Key Companies Regenerative Medicine Product Offered
2.5 Key Companies Time to Begin Mass Production of Regenerative Medicine
2.6 Regenerative Medicine Market Competitive Analysis
2.6.1 Regenerative Medicine Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Regenerative Medicine Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cell Therapy
3.1.2 Tissue Engineering
3.1.3 Biomaterial
3.1.4 Other
3.2 Global Regenerative Medicine Sales Value by Type
3.2.1 Global Regenerative Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Regenerative Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Regenerative Medicine Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Dermatology
4.1.2 Cardiovascular
4.1.3 CNS
4.1.4 Orthopedic
4.1.5 Others
4.2 Global Regenerative Medicine Sales Value by Application
4.2.1 Global Regenerative Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Regenerative Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Regenerative Medicine Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Regenerative Medicine Sales Value by Region
5.1.1 Global Regenerative Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Regenerative Medicine Sales Value by Region (2019-2024)
5.1.3 Global Regenerative Medicine Sales Value by Region (2025-2030)
5.1.4 Global Regenerative Medicine Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Regenerative Medicine Sales Value, 2019-2030
5.2.2 North America Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Regenerative Medicine Sales Value, 2019-2030
5.3.2 Europe Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Regenerative Medicine Sales Value, 2019-2030
5.4.2 Asia Pacific Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Regenerative Medicine Sales Value, 2019-2030
5.5.2 South America Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Regenerative Medicine Sales Value, 2019-2030
5.6.2 Middle East & Africa Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Regenerative Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Regenerative Medicine Sales Value
6.3 United States
6.3.1 United States Regenerative Medicine Sales Value, 2019-2030
6.3.2 United States Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Regenerative Medicine Sales Value, 2019-2030
6.4.2 Europe Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Regenerative Medicine Sales Value, 2019-2030
6.5.2 China Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Regenerative Medicine Sales Value, 2019-2030
6.6.2 Japan Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Regenerative Medicine Sales Value, 2019-2030
6.7.2 South Korea Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Regenerative Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Regenerative Medicine Sales Value, 2019-2030
6.9.2 India Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Regenerative Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 J & J (DePuy Synthes)
7.1.1 J & J (DePuy Synthes) Profile
7.1.2 J & J (DePuy Synthes) Main Business
7.1.3 J & J (DePuy Synthes) Regenerative Medicine Products, Services and Solutions
7.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.1.5 J & J (DePuy Synthes) Recent Developments
7.2 Medtronic
7.2.1 Medtronic Profile
7.2.2 Medtronic Main Business
7.2.3 Medtronic Regenerative Medicine Products, Services and Solutions
7.2.4 Medtronic Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.2.5 Medtronic Recent Developments
7.3 Zimmer Biomet
7.3.1 Zimmer Biomet Profile
7.3.2 Zimmer Biomet Main Business
7.3.3 Zimmer Biomet Regenerative Medicine Products, Services and Solutions
7.3.4 Zimmer Biomet Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.3.5 Stryker Recent Developments
7.4 Stryker
7.4.1 Stryker Profile
7.4.2 Stryker Main Business
7.4.3 Stryker Regenerative Medicine Products, Services and Solutions
7.4.4 Stryker Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.4.5 Stryker Recent Developments
7.5 Allergan(Acelity)
7.5.1 Allergan(Acelity) Profile
7.5.2 Allergan(Acelity) Main Business
7.5.3 Allergan(Acelity) Regenerative Medicine Products, Services and Solutions
7.5.4 Allergan(Acelity) Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.5.5 Allergan(Acelity) Recent Developments
7.6 MiMedx Group
7.6.1 MiMedx Group Profile
7.6.2 MiMedx Group Main Business
7.6.3 MiMedx Group Regenerative Medicine Products, Services and Solutions
7.6.4 MiMedx Group Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.6.5 MiMedx Group Recent Developments
7.7 Organogenesis
7.7.1 Organogenesis Profile
7.7.2 Organogenesis Main Business
7.7.3 Organogenesis Regenerative Medicine Products, Services and Solutions
7.7.4 Organogenesis Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.7.5 Organogenesis Recent Developments
7.8 Fujifilm Cellular Dynamics
7.8.1 Fujifilm Cellular Dynamics Profile
7.8.2 Fujifilm Cellular Dynamics Main Business
7.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Products, Services and Solutions
7.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.8.5 Fujifilm Cellular Dynamics Recent Developments
7.9 Osiris Therapeutics
7.9.1 Osiris Therapeutics Profile
7.9.2 Osiris Therapeutics Main Business
7.9.3 Osiris Therapeutics Regenerative Medicine Products, Services and Solutions
7.9.4 Osiris Therapeutics Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.9.5 Osiris Therapeutics Recent Developments
7.10 Vcanbio
7.10.1 Vcanbio Profile
7.10.2 Vcanbio Main Business
7.10.3 Vcanbio Regenerative Medicine Products, Services and Solutions
7.10.4 Vcanbio Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.10.5 Vcanbio Recent Developments
7.11 CCBC
7.11.1 CCBC Profile
7.11.2 CCBC Main Business
7.11.3 CCBC Regenerative Medicine Products, Services and Solutions
7.11.4 CCBC Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.11.5 CCBC Recent Developments
7.12 Cytori
7.12.1 Cytori Profile
7.12.2 Cytori Main Business
7.12.3 Cytori Regenerative Medicine Products, Services and Solutions
7.12.4 Cytori Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.12.5 Cytori Recent Developments
7.13 Celgene
7.13.1 Celgene Profile
7.13.2 Celgene Main Business
7.13.3 Celgene Regenerative Medicine Products, Services and Solutions
7.13.4 Celgene Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.13.5 Celgene Recent Developments
7.14 Vericel Corporation
7.14.1 Vericel Corporation Profile
7.14.2 Vericel Corporation Main Business
7.14.3 Vericel Corporation Regenerative Medicine Products, Services and Solutions
7.14.4 Vericel Corporation Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.14.5 Vericel Corporation Recent Developments
7.15 Guanhao Biotech
7.15.1 Guanhao Biotech Profile
7.15.2 Guanhao Biotech Main Business
7.15.3 Guanhao Biotech Regenerative Medicine Products, Services and Solutions
7.15.4 Guanhao Biotech Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.15.5 Guanhao Biotech Recent Developments
7.16 Mesoblast
7.16.1 Mesoblast Profile
7.16.2 Mesoblast Main Business
7.16.3 Mesoblast Regenerative Medicine Products, Services and Solutions
7.16.4 Mesoblast Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.16.5 Mesoblast Recent Developments
7.17 AMAG Pharmaceuticals (CBR)
7.17.1 AMAG Pharmaceuticals (CBR) Profile
7.17.2 AMAG Pharmaceuticals (CBR) Main Business
7.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Products, Services and Solutions
7.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.17.5 AMAG Pharmaceuticals (CBR) Recent Developments
7.18 ViaCord
7.18.1 ViaCord Profile
7.18.2 ViaCord Main Business
7.18.3 ViaCord Regenerative Medicine Products, Services and Solutions
7.18.4 ViaCord Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.18.5 ViaCord Recent Developments
7.19 CordLife
7.19.1 CordLife Profile
7.19.2 CordLife Main Business
7.19.3 CordLife Regenerative Medicine Products, Services and Solutions
7.19.4 CordLife Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.19.5 CordLife Recent Developments
7.20 Integra LifeSciences
7.20.1 Integra LifeSciences Profile
7.20.2 Integra LifeSciences Main Business
7.20.3 Integra LifeSciences Regenerative Medicine Products, Services and Solutions
7.20.4 Integra LifeSciences Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.20.5 Integra LifeSciences Recent Developments
7.21 Nuvasive
7.21.1 Nuvasive Profile
7.21.2 Nuvasive Main Business
7.21.3 Nuvasive Regenerative Medicine Products, Services and Solutions
7.21.4 Nuvasive Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.21.5 Nuvasive Recent Developments
7.22 Cook Biotech
7.22.1 Cook Biotech Profile
7.22.2 Cook Biotech Main Business
7.22.3 Cook Biotech Regenerative Medicine Products, Services and Solutions
7.22.4 Cook Biotech Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.22.5 Cook Biotech Recent Developments
7.23 Japan Tissue Engineering
7.23.1 Japan Tissue Engineering Profile
7.23.2 Japan Tissue Engineering Main Business
7.23.3 Japan Tissue Engineering Regenerative Medicine Products, Services and Solutions
7.23.4 Japan Tissue Engineering Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.23.5 Japan Tissue Engineering Recent Developments
8 Industry Chain Analysis
8.1 Regenerative Medicine Industrial Chain
8.2 Regenerative Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Regenerative Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Regenerative Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Regenerative Medicine Product Introduction
1.2 Global Regenerative Medicine Market Size Forecast
1.3 Regenerative Medicine Market Trends & Drivers
1.3.1 Regenerative Medicine Industry Trends
1.3.2 Regenerative Medicine Market Drivers & Opportunity
1.3.3 Regenerative Medicine Market Challenges
1.3.4 Regenerative Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Regenerative Medicine Players Revenue Ranking (2023)
2.2 Global Regenerative Medicine Revenue by Company (2019-2024)
2.3 Key Companies Regenerative Medicine Manufacturing Base Distribution and Headquarters
2.4 Key Companies Regenerative Medicine Product Offered
2.5 Key Companies Time to Begin Mass Production of Regenerative Medicine
2.6 Regenerative Medicine Market Competitive Analysis
2.6.1 Regenerative Medicine Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Regenerative Medicine Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cell Therapy
3.1.2 Tissue Engineering
3.1.3 Biomaterial
3.1.4 Other
3.2 Global Regenerative Medicine Sales Value by Type
3.2.1 Global Regenerative Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Regenerative Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Regenerative Medicine Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Dermatology
4.1.2 Cardiovascular
4.1.3 CNS
4.1.4 Orthopedic
4.1.5 Others
4.2 Global Regenerative Medicine Sales Value by Application
4.2.1 Global Regenerative Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Regenerative Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Regenerative Medicine Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Regenerative Medicine Sales Value by Region
5.1.1 Global Regenerative Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Regenerative Medicine Sales Value by Region (2019-2024)
5.1.3 Global Regenerative Medicine Sales Value by Region (2025-2030)
5.1.4 Global Regenerative Medicine Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Regenerative Medicine Sales Value, 2019-2030
5.2.2 North America Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Regenerative Medicine Sales Value, 2019-2030
5.3.2 Europe Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Regenerative Medicine Sales Value, 2019-2030
5.4.2 Asia Pacific Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Regenerative Medicine Sales Value, 2019-2030
5.5.2 South America Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Regenerative Medicine Sales Value, 2019-2030
5.6.2 Middle East & Africa Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Regenerative Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Regenerative Medicine Sales Value
6.3 United States
6.3.1 United States Regenerative Medicine Sales Value, 2019-2030
6.3.2 United States Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Regenerative Medicine Sales Value, 2019-2030
6.4.2 Europe Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Regenerative Medicine Sales Value, 2019-2030
6.5.2 China Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Regenerative Medicine Sales Value, 2019-2030
6.6.2 Japan Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Regenerative Medicine Sales Value, 2019-2030
6.7.2 South Korea Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Regenerative Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Regenerative Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Regenerative Medicine Sales Value, 2019-2030
6.9.2 India Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Regenerative Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 J & J (DePuy Synthes)
7.1.1 J & J (DePuy Synthes) Profile
7.1.2 J & J (DePuy Synthes) Main Business
7.1.3 J & J (DePuy Synthes) Regenerative Medicine Products, Services and Solutions
7.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.1.5 J & J (DePuy Synthes) Recent Developments
7.2 Medtronic
7.2.1 Medtronic Profile
7.2.2 Medtronic Main Business
7.2.3 Medtronic Regenerative Medicine Products, Services and Solutions
7.2.4 Medtronic Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.2.5 Medtronic Recent Developments
7.3 Zimmer Biomet
7.3.1 Zimmer Biomet Profile
7.3.2 Zimmer Biomet Main Business
7.3.3 Zimmer Biomet Regenerative Medicine Products, Services and Solutions
7.3.4 Zimmer Biomet Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.3.5 Stryker Recent Developments
7.4 Stryker
7.4.1 Stryker Profile
7.4.2 Stryker Main Business
7.4.3 Stryker Regenerative Medicine Products, Services and Solutions
7.4.4 Stryker Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.4.5 Stryker Recent Developments
7.5 Allergan(Acelity)
7.5.1 Allergan(Acelity) Profile
7.5.2 Allergan(Acelity) Main Business
7.5.3 Allergan(Acelity) Regenerative Medicine Products, Services and Solutions
7.5.4 Allergan(Acelity) Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.5.5 Allergan(Acelity) Recent Developments
7.6 MiMedx Group
7.6.1 MiMedx Group Profile
7.6.2 MiMedx Group Main Business
7.6.3 MiMedx Group Regenerative Medicine Products, Services and Solutions
7.6.4 MiMedx Group Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.6.5 MiMedx Group Recent Developments
7.7 Organogenesis
7.7.1 Organogenesis Profile
7.7.2 Organogenesis Main Business
7.7.3 Organogenesis Regenerative Medicine Products, Services and Solutions
7.7.4 Organogenesis Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.7.5 Organogenesis Recent Developments
7.8 Fujifilm Cellular Dynamics
7.8.1 Fujifilm Cellular Dynamics Profile
7.8.2 Fujifilm Cellular Dynamics Main Business
7.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Products, Services and Solutions
7.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.8.5 Fujifilm Cellular Dynamics Recent Developments
7.9 Osiris Therapeutics
7.9.1 Osiris Therapeutics Profile
7.9.2 Osiris Therapeutics Main Business
7.9.3 Osiris Therapeutics Regenerative Medicine Products, Services and Solutions
7.9.4 Osiris Therapeutics Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.9.5 Osiris Therapeutics Recent Developments
7.10 Vcanbio
7.10.1 Vcanbio Profile
7.10.2 Vcanbio Main Business
7.10.3 Vcanbio Regenerative Medicine Products, Services and Solutions
7.10.4 Vcanbio Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.10.5 Vcanbio Recent Developments
7.11 CCBC
7.11.1 CCBC Profile
7.11.2 CCBC Main Business
7.11.3 CCBC Regenerative Medicine Products, Services and Solutions
7.11.4 CCBC Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.11.5 CCBC Recent Developments
7.12 Cytori
7.12.1 Cytori Profile
7.12.2 Cytori Main Business
7.12.3 Cytori Regenerative Medicine Products, Services and Solutions
7.12.4 Cytori Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.12.5 Cytori Recent Developments
7.13 Celgene
7.13.1 Celgene Profile
7.13.2 Celgene Main Business
7.13.3 Celgene Regenerative Medicine Products, Services and Solutions
7.13.4 Celgene Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.13.5 Celgene Recent Developments
7.14 Vericel Corporation
7.14.1 Vericel Corporation Profile
7.14.2 Vericel Corporation Main Business
7.14.3 Vericel Corporation Regenerative Medicine Products, Services and Solutions
7.14.4 Vericel Corporation Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.14.5 Vericel Corporation Recent Developments
7.15 Guanhao Biotech
7.15.1 Guanhao Biotech Profile
7.15.2 Guanhao Biotech Main Business
7.15.3 Guanhao Biotech Regenerative Medicine Products, Services and Solutions
7.15.4 Guanhao Biotech Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.15.5 Guanhao Biotech Recent Developments
7.16 Mesoblast
7.16.1 Mesoblast Profile
7.16.2 Mesoblast Main Business
7.16.3 Mesoblast Regenerative Medicine Products, Services and Solutions
7.16.4 Mesoblast Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.16.5 Mesoblast Recent Developments
7.17 AMAG Pharmaceuticals (CBR)
7.17.1 AMAG Pharmaceuticals (CBR) Profile
7.17.2 AMAG Pharmaceuticals (CBR) Main Business
7.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Products, Services and Solutions
7.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.17.5 AMAG Pharmaceuticals (CBR) Recent Developments
7.18 ViaCord
7.18.1 ViaCord Profile
7.18.2 ViaCord Main Business
7.18.3 ViaCord Regenerative Medicine Products, Services and Solutions
7.18.4 ViaCord Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.18.5 ViaCord Recent Developments
7.19 CordLife
7.19.1 CordLife Profile
7.19.2 CordLife Main Business
7.19.3 CordLife Regenerative Medicine Products, Services and Solutions
7.19.4 CordLife Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.19.5 CordLife Recent Developments
7.20 Integra LifeSciences
7.20.1 Integra LifeSciences Profile
7.20.2 Integra LifeSciences Main Business
7.20.3 Integra LifeSciences Regenerative Medicine Products, Services and Solutions
7.20.4 Integra LifeSciences Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.20.5 Integra LifeSciences Recent Developments
7.21 Nuvasive
7.21.1 Nuvasive Profile
7.21.2 Nuvasive Main Business
7.21.3 Nuvasive Regenerative Medicine Products, Services and Solutions
7.21.4 Nuvasive Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.21.5 Nuvasive Recent Developments
7.22 Cook Biotech
7.22.1 Cook Biotech Profile
7.22.2 Cook Biotech Main Business
7.22.3 Cook Biotech Regenerative Medicine Products, Services and Solutions
7.22.4 Cook Biotech Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.22.5 Cook Biotech Recent Developments
7.23 Japan Tissue Engineering
7.23.1 Japan Tissue Engineering Profile
7.23.2 Japan Tissue Engineering Main Business
7.23.3 Japan Tissue Engineering Regenerative Medicine Products, Services and Solutions
7.23.4 Japan Tissue Engineering Regenerative Medicine Revenue (US$ Million) & (2019-2024)
7.23.5 Japan Tissue Engineering Recent Developments
8 Industry Chain Analysis
8.1 Regenerative Medicine Industrial Chain
8.2 Regenerative Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Regenerative Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Regenerative Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Regenerative Medicine Market Trends
Table 2. Regenerative Medicine Market Drivers & Opportunity
Table 3. Regenerative Medicine Market Challenges
Table 4. Regenerative Medicine Market Restraints
Table 5. Global Regenerative Medicine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Regenerative Medicine Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Regenerative Medicine Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Regenerative Medicine Product Type
Table 9. Key Companies Time to Begin Mass Production of Regenerative Medicine
Table 10. Global Regenerative Medicine Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Regenerative Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Regenerative Medicine Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Regenerative Medicine Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Regenerative Medicine Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Regenerative Medicine Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Regenerative Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Regenerative Medicine Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Regenerative Medicine Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Regenerative Medicine Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Regenerative Medicine Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Regenerative Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Regenerative Medicine Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Regenerative Medicine Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Regenerative Medicine Sales Value by Region (2019-2024) & (%)
Table 27. Global Regenerative Medicine Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Regenerative Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Regenerative Medicine Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Regenerative Medicine Sales Value, (2025-2030) & (US$ Million)
Table 31. J & J (DePuy Synthes) Basic Information List
Table 32. J & J (DePuy Synthes) Description and Business Overview
Table 33. J & J (DePuy Synthes) Regenerative Medicine Products, Services and Solutions
Table 34. Revenue (US$ Million) in Regenerative Medicine Business of J & J (DePuy Synthes) (2019-2024)
Table 35. J & J (DePuy Synthes) Recent Developments
Table 36. Medtronic Basic Information List
Table 37. Medtronic Description and Business Overview
Table 38. Medtronic Regenerative Medicine Products, Services and Solutions
Table 39. Revenue (US$ Million) in Regenerative Medicine Business of Medtronic (2019-2024)
Table 40. Medtronic Recent Developments
Table 41. Zimmer Biomet Basic Information List
Table 42. Zimmer Biomet Description and Business Overview
Table 43. Zimmer Biomet Regenerative Medicine Products, Services and Solutions
Table 44. Revenue (US$ Million) in Regenerative Medicine Business of Zimmer Biomet (2019-2024)
Table 45. Zimmer Biomet Recent Developments
Table 46. Stryker Basic Information List
Table 47. Stryker Description and Business Overview
Table 48. Stryker Regenerative Medicine Products, Services and Solutions
Table 49. Revenue (US$ Million) in Regenerative Medicine Business of Stryker (2019-2024)
Table 50. Stryker Recent Developments
Table 51. Allergan(Acelity) Basic Information List
Table 52. Allergan(Acelity) Description and Business Overview
Table 53. Allergan(Acelity) Regenerative Medicine Products, Services and Solutions
Table 54. Revenue (US$ Million) in Regenerative Medicine Business of Allergan(Acelity) (2019-2024)
Table 55. Allergan(Acelity) Recent Developments
Table 56. MiMedx Group Basic Information List
Table 57. MiMedx Group Description and Business Overview
Table 58. MiMedx Group Regenerative Medicine Products, Services and Solutions
Table 59. Revenue (US$ Million) in Regenerative Medicine Business of MiMedx Group (2019-2024)
Table 60. MiMedx Group Recent Developments
Table 61. Organogenesis Basic Information List
Table 62. Organogenesis Description and Business Overview
Table 63. Organogenesis Regenerative Medicine Products, Services and Solutions
Table 64. Revenue (US$ Million) in Regenerative Medicine Business of Organogenesis (2019-2024)
Table 65. Organogenesis Recent Developments
Table 66. Fujifilm Cellular Dynamics Basic Information List
Table 67. Fujifilm Cellular Dynamics Description and Business Overview
Table 68. Fujifilm Cellular Dynamics Regenerative Medicine Products, Services and Solutions
Table 69. Revenue (US$ Million) in Regenerative Medicine Business of Fujifilm Cellular Dynamics (2019-2024)
Table 70. Fujifilm Cellular Dynamics Recent Developments
Table 71. Osiris Therapeutics Basic Information List
Table 72. Osiris Therapeutics Description and Business Overview
Table 73. Osiris Therapeutics Regenerative Medicine Products, Services and Solutions
Table 74. Revenue (US$ Million) in Regenerative Medicine Business of Osiris Therapeutics (2019-2024)
Table 75. Osiris Therapeutics Recent Developments
Table 76. Vcanbio Basic Information List
Table 77. Vcanbio Description and Business Overview
Table 78. Vcanbio Regenerative Medicine Products, Services and Solutions
Table 79. Revenue (US$ Million) in Regenerative Medicine Business of Vcanbio (2019-2024)
Table 80. Vcanbio Recent Developments
Table 81. CCBC Basic Information List
Table 82. CCBC Description and Business Overview
Table 83. CCBC Regenerative Medicine Products, Services and Solutions
Table 84. Revenue (US$ Million) in Regenerative Medicine Business of CCBC (2019-2024)
Table 85. CCBC Recent Developments
Table 86. Cytori Basic Information List
Table 87. Cytori Description and Business Overview
Table 88. Cytori Regenerative Medicine Products, Services and Solutions
Table 89. Revenue (US$ Million) in Regenerative Medicine Business of Cytori (2019-2024)
Table 90. Cytori Recent Developments
Table 91. Celgene Basic Information List
Table 92. Celgene Description and Business Overview
Table 93. Celgene Regenerative Medicine Products, Services and Solutions
Table 94. Revenue (US$ Million) in Regenerative Medicine Business of Celgene (2019-2024)
Table 95. Celgene Recent Developments
Table 96. Vericel Corporation Basic Information List
Table 97. Vericel Corporation Description and Business Overview
Table 98. Vericel Corporation Regenerative Medicine Products, Services and Solutions
Table 99. Revenue (US$ Million) in Regenerative Medicine Business of Vericel Corporation (2019-2024)
Table 100. Vericel Corporation Recent Developments
Table 101. Guanhao Biotech Basic Information List
Table 102. Guanhao Biotech Description and Business Overview
Table 103. Guanhao Biotech Regenerative Medicine Products, Services and Solutions
Table 104. Revenue (US$ Million) in Regenerative Medicine Business of Guanhao Biotech (2019-2024)
Table 105. Guanhao Biotech Recent Developments
Table 106. Mesoblast Basic Information List
Table 107. Mesoblast Description and Business Overview
Table 108. Mesoblast Regenerative Medicine Products, Services and Solutions
Table 109. Revenue (US$ Million) in Regenerative Medicine Business of Mesoblast (2019-2024)
Table 110. Mesoblast Recent Developments
Table 111. AMAG Pharmaceuticals (CBR) Basic Information List
Table 112. AMAG Pharmaceuticals (CBR) Description and Business Overview
Table 113. AMAG Pharmaceuticals (CBR) Regenerative Medicine Products, Services and Solutions
Table 114. Revenue (US$ Million) in Regenerative Medicine Business of AMAG Pharmaceuticals (CBR) (2019-2024)
Table 115. AMAG Pharmaceuticals (CBR) Recent Developments
Table 116. ViaCord Basic Information List
Table 117. ViaCord Description and Business Overview
Table 118. ViaCord Regenerative Medicine Products, Services and Solutions
Table 119. Revenue (US$ Million) in Regenerative Medicine Business of ViaCord (2019-2024)
Table 120. ViaCord Recent Developments
Table 121. CordLife Basic Information List
Table 122. CordLife Description and Business Overview
Table 123. CordLife Regenerative Medicine Products, Services and Solutions
Table 124. Revenue (US$ Million) in Regenerative Medicine Business of CordLife (2019-2024)
Table 125. CordLife Recent Developments
Table 126. Integra LifeSciences Basic Information List
Table 127. Integra LifeSciences Description and Business Overview
Table 128. Integra LifeSciences Regenerative Medicine Products, Services and Solutions
Table 129. Revenue (US$ Million) in Regenerative Medicine Business of Integra LifeSciences (2019-2024)
Table 130. Integra LifeSciences Recent Developments
Table 131. Nuvasive Basic Information List
Table 132. Nuvasive Description and Business Overview
Table 133. Nuvasive Regenerative Medicine Products, Services and Solutions
Table 134. Revenue (US$ Million) in Regenerative Medicine Business of Nuvasive (2019-2024)
Table 135. Nuvasive Recent Developments
Table 136. Cook Biotech Basic Information List
Table 137. Cook Biotech Description and Business Overview
Table 138. Cook Biotech Regenerative Medicine Products, Services and Solutions
Table 139. Revenue (US$ Million) in Regenerative Medicine Business of Cook Biotech (2019-2024)
Table 140. Cook Biotech Recent Developments
Table 141. Japan Tissue Engineering Basic Information List
Table 142. Japan Tissue Engineering Description and Business Overview
Table 143. Japan Tissue Engineering Regenerative Medicine Products, Services and Solutions
Table 144. Revenue (US$ Million) in Regenerative Medicine Business of Japan Tissue Engineering (2019-2024)
Table 145. Japan Tissue Engineering Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Regenerative Medicine Downstream Customers
Table 149. Regenerative Medicine Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Regenerative Medicine Product Picture
Figure 2. Global Regenerative Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 4. Regenerative Medicine Report Years Considered
Figure 5. Global Regenerative Medicine Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Regenerative Medicine Revenue in 2023
Figure 7. Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Cell Therapy Picture
Figure 9. Tissue Engineering Picture
Figure 10. Biomaterial Picture
Figure 11. Other Picture
Figure 12. Global Regenerative Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Regenerative Medicine Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Dermatology
Figure 15. Product Picture of Cardiovascular
Figure 16. Product Picture of CNS
Figure 17. Product Picture of Orthopedic
Figure 18. Product Picture of Others
Figure 19. Global Regenerative Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Regenerative Medicine Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Regenerative Medicine Sales Value (%), (2019-2030)
Figure 32. United States Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 38. China Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 40. China Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 50. India Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 52. India Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 53. Regenerative Medicine Industrial Chain
Figure 54. Regenerative Medicine Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Table 1. Regenerative Medicine Market Trends
Table 2. Regenerative Medicine Market Drivers & Opportunity
Table 3. Regenerative Medicine Market Challenges
Table 4. Regenerative Medicine Market Restraints
Table 5. Global Regenerative Medicine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Regenerative Medicine Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Regenerative Medicine Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Regenerative Medicine Product Type
Table 9. Key Companies Time to Begin Mass Production of Regenerative Medicine
Table 10. Global Regenerative Medicine Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Regenerative Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Regenerative Medicine Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Regenerative Medicine Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Regenerative Medicine Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Regenerative Medicine Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Regenerative Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Regenerative Medicine Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Regenerative Medicine Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Regenerative Medicine Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Regenerative Medicine Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Regenerative Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Regenerative Medicine Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Regenerative Medicine Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Regenerative Medicine Sales Value by Region (2019-2024) & (%)
Table 27. Global Regenerative Medicine Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Regenerative Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Regenerative Medicine Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Regenerative Medicine Sales Value, (2025-2030) & (US$ Million)
Table 31. J & J (DePuy Synthes) Basic Information List
Table 32. J & J (DePuy Synthes) Description and Business Overview
Table 33. J & J (DePuy Synthes) Regenerative Medicine Products, Services and Solutions
Table 34. Revenue (US$ Million) in Regenerative Medicine Business of J & J (DePuy Synthes) (2019-2024)
Table 35. J & J (DePuy Synthes) Recent Developments
Table 36. Medtronic Basic Information List
Table 37. Medtronic Description and Business Overview
Table 38. Medtronic Regenerative Medicine Products, Services and Solutions
Table 39. Revenue (US$ Million) in Regenerative Medicine Business of Medtronic (2019-2024)
Table 40. Medtronic Recent Developments
Table 41. Zimmer Biomet Basic Information List
Table 42. Zimmer Biomet Description and Business Overview
Table 43. Zimmer Biomet Regenerative Medicine Products, Services and Solutions
Table 44. Revenue (US$ Million) in Regenerative Medicine Business of Zimmer Biomet (2019-2024)
Table 45. Zimmer Biomet Recent Developments
Table 46. Stryker Basic Information List
Table 47. Stryker Description and Business Overview
Table 48. Stryker Regenerative Medicine Products, Services and Solutions
Table 49. Revenue (US$ Million) in Regenerative Medicine Business of Stryker (2019-2024)
Table 50. Stryker Recent Developments
Table 51. Allergan(Acelity) Basic Information List
Table 52. Allergan(Acelity) Description and Business Overview
Table 53. Allergan(Acelity) Regenerative Medicine Products, Services and Solutions
Table 54. Revenue (US$ Million) in Regenerative Medicine Business of Allergan(Acelity) (2019-2024)
Table 55. Allergan(Acelity) Recent Developments
Table 56. MiMedx Group Basic Information List
Table 57. MiMedx Group Description and Business Overview
Table 58. MiMedx Group Regenerative Medicine Products, Services and Solutions
Table 59. Revenue (US$ Million) in Regenerative Medicine Business of MiMedx Group (2019-2024)
Table 60. MiMedx Group Recent Developments
Table 61. Organogenesis Basic Information List
Table 62. Organogenesis Description and Business Overview
Table 63. Organogenesis Regenerative Medicine Products, Services and Solutions
Table 64. Revenue (US$ Million) in Regenerative Medicine Business of Organogenesis (2019-2024)
Table 65. Organogenesis Recent Developments
Table 66. Fujifilm Cellular Dynamics Basic Information List
Table 67. Fujifilm Cellular Dynamics Description and Business Overview
Table 68. Fujifilm Cellular Dynamics Regenerative Medicine Products, Services and Solutions
Table 69. Revenue (US$ Million) in Regenerative Medicine Business of Fujifilm Cellular Dynamics (2019-2024)
Table 70. Fujifilm Cellular Dynamics Recent Developments
Table 71. Osiris Therapeutics Basic Information List
Table 72. Osiris Therapeutics Description and Business Overview
Table 73. Osiris Therapeutics Regenerative Medicine Products, Services and Solutions
Table 74. Revenue (US$ Million) in Regenerative Medicine Business of Osiris Therapeutics (2019-2024)
Table 75. Osiris Therapeutics Recent Developments
Table 76. Vcanbio Basic Information List
Table 77. Vcanbio Description and Business Overview
Table 78. Vcanbio Regenerative Medicine Products, Services and Solutions
Table 79. Revenue (US$ Million) in Regenerative Medicine Business of Vcanbio (2019-2024)
Table 80. Vcanbio Recent Developments
Table 81. CCBC Basic Information List
Table 82. CCBC Description and Business Overview
Table 83. CCBC Regenerative Medicine Products, Services and Solutions
Table 84. Revenue (US$ Million) in Regenerative Medicine Business of CCBC (2019-2024)
Table 85. CCBC Recent Developments
Table 86. Cytori Basic Information List
Table 87. Cytori Description and Business Overview
Table 88. Cytori Regenerative Medicine Products, Services and Solutions
Table 89. Revenue (US$ Million) in Regenerative Medicine Business of Cytori (2019-2024)
Table 90. Cytori Recent Developments
Table 91. Celgene Basic Information List
Table 92. Celgene Description and Business Overview
Table 93. Celgene Regenerative Medicine Products, Services and Solutions
Table 94. Revenue (US$ Million) in Regenerative Medicine Business of Celgene (2019-2024)
Table 95. Celgene Recent Developments
Table 96. Vericel Corporation Basic Information List
Table 97. Vericel Corporation Description and Business Overview
Table 98. Vericel Corporation Regenerative Medicine Products, Services and Solutions
Table 99. Revenue (US$ Million) in Regenerative Medicine Business of Vericel Corporation (2019-2024)
Table 100. Vericel Corporation Recent Developments
Table 101. Guanhao Biotech Basic Information List
Table 102. Guanhao Biotech Description and Business Overview
Table 103. Guanhao Biotech Regenerative Medicine Products, Services and Solutions
Table 104. Revenue (US$ Million) in Regenerative Medicine Business of Guanhao Biotech (2019-2024)
Table 105. Guanhao Biotech Recent Developments
Table 106. Mesoblast Basic Information List
Table 107. Mesoblast Description and Business Overview
Table 108. Mesoblast Regenerative Medicine Products, Services and Solutions
Table 109. Revenue (US$ Million) in Regenerative Medicine Business of Mesoblast (2019-2024)
Table 110. Mesoblast Recent Developments
Table 111. AMAG Pharmaceuticals (CBR) Basic Information List
Table 112. AMAG Pharmaceuticals (CBR) Description and Business Overview
Table 113. AMAG Pharmaceuticals (CBR) Regenerative Medicine Products, Services and Solutions
Table 114. Revenue (US$ Million) in Regenerative Medicine Business of AMAG Pharmaceuticals (CBR) (2019-2024)
Table 115. AMAG Pharmaceuticals (CBR) Recent Developments
Table 116. ViaCord Basic Information List
Table 117. ViaCord Description and Business Overview
Table 118. ViaCord Regenerative Medicine Products, Services and Solutions
Table 119. Revenue (US$ Million) in Regenerative Medicine Business of ViaCord (2019-2024)
Table 120. ViaCord Recent Developments
Table 121. CordLife Basic Information List
Table 122. CordLife Description and Business Overview
Table 123. CordLife Regenerative Medicine Products, Services and Solutions
Table 124. Revenue (US$ Million) in Regenerative Medicine Business of CordLife (2019-2024)
Table 125. CordLife Recent Developments
Table 126. Integra LifeSciences Basic Information List
Table 127. Integra LifeSciences Description and Business Overview
Table 128. Integra LifeSciences Regenerative Medicine Products, Services and Solutions
Table 129. Revenue (US$ Million) in Regenerative Medicine Business of Integra LifeSciences (2019-2024)
Table 130. Integra LifeSciences Recent Developments
Table 131. Nuvasive Basic Information List
Table 132. Nuvasive Description and Business Overview
Table 133. Nuvasive Regenerative Medicine Products, Services and Solutions
Table 134. Revenue (US$ Million) in Regenerative Medicine Business of Nuvasive (2019-2024)
Table 135. Nuvasive Recent Developments
Table 136. Cook Biotech Basic Information List
Table 137. Cook Biotech Description and Business Overview
Table 138. Cook Biotech Regenerative Medicine Products, Services and Solutions
Table 139. Revenue (US$ Million) in Regenerative Medicine Business of Cook Biotech (2019-2024)
Table 140. Cook Biotech Recent Developments
Table 141. Japan Tissue Engineering Basic Information List
Table 142. Japan Tissue Engineering Description and Business Overview
Table 143. Japan Tissue Engineering Regenerative Medicine Products, Services and Solutions
Table 144. Revenue (US$ Million) in Regenerative Medicine Business of Japan Tissue Engineering (2019-2024)
Table 145. Japan Tissue Engineering Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Regenerative Medicine Downstream Customers
Table 149. Regenerative Medicine Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Regenerative Medicine Product Picture
Figure 2. Global Regenerative Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 4. Regenerative Medicine Report Years Considered
Figure 5. Global Regenerative Medicine Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Regenerative Medicine Revenue in 2023
Figure 7. Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Cell Therapy Picture
Figure 9. Tissue Engineering Picture
Figure 10. Biomaterial Picture
Figure 11. Other Picture
Figure 12. Global Regenerative Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Regenerative Medicine Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Dermatology
Figure 15. Product Picture of Cardiovascular
Figure 16. Product Picture of CNS
Figure 17. Product Picture of Orthopedic
Figure 18. Product Picture of Others
Figure 19. Global Regenerative Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Regenerative Medicine Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Regenerative Medicine Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Regenerative Medicine Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Regenerative Medicine Sales Value (%), (2019-2030)
Figure 32. United States Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 38. China Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 40. China Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 50. India Regenerative Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Regenerative Medicine Sales Value by Type (%), 2023 VS 2030
Figure 52. India Regenerative Medicine Sales Value by Application (%), 2023 VS 2030
Figure 53. Regenerative Medicine Industrial Chain
Figure 54. Regenerative Medicine Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232